Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk-directed Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01570465
What this trial is testing

Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients

Who this might be right for
AMLAdult
Gruppo Italiano Malattie EMatologiche dell'Adulto 144
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Not applicableStudy completedNCT04302467
What this trial is testing

Effects of Intraoperative Fluid Therapy on Acute Kidney Injury After Thoracoscopic Lobectomy

Who this might be right for
Acute Kidney Injury
First Affiliated Hospital Xi'an Jiaotong University 276
Testing effectiveness (Phase 2)Looking for participantsNCT07175480
What this trial is testing

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT02870777
What this trial is testing

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual Disease
Nanfang Hospital, Southern Medical University 743
Testing effectiveness (Phase 2)Looking for participantsNCT05062317
What this trial is testing

CtDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases

Who this might be right for
Liver Metastases
M.D. Anderson Cancer Center 120
Not applicableStudy completedNCT04792242
What this trial is testing

Effect of PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries

Who this might be right for
Major Abdominal Surgeries
South Valley University 40
Testing effectiveness (Phase 2)Study completedNCT01452646
What this trial is testing

Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 515
Not applicableStudy completedNCT02834377
What this trial is testing

Personalized Hemodynamic Therapy in Patients Undergoing High-risk Surgery

Who this might be right for
Postoperative Complications
Universitätsklinikum Hamburg-Eppendorf 188
Not applicableStudy completedNCT05212649
What this trial is testing

Optimized Peak VO2 in Predicting Advanced HF

Who this might be right for
Heart FailureMoralityTransplant; Failure, Heart
Chang Gung Memorial Hospital 377
Testing effectiveness (Phase 2)Active Not RecruitingNCT05767359
What this trial is testing

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT04137991
What this trial is testing

Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery

Who this might be right for
Nociceptive PainGoal-directed TherapyHemodynamic Instability+5 more
Erasme University Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Testing effectiveness (Phase 2)Study completedNCT00254150
What this trial is testing

A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients

Who this might be right for
High-Risk Surgical Patients
Università Politecnica delle Marche 130
Not applicableLooking for participantsNCT05824260
What this trial is testing

Risk Factors for Postoperative Complications in Major Non-cardiac Surgery: Post-hoc Analysis of the OPHIQUE Multicentre Study

Who this might be right for
Goal Directed TherapyPostoperative MorbidityIndividualised Target+1 more
Centre Hospitalier Universitaire, Amiens 350
Large-scale testing (Phase 3)UnknownNCT01946269
What this trial is testing

Goal-Directed Therapy in Cancer Surgery

Who this might be right for
Postoperative Care
University of Sao Paulo 128
Large-scale testing (Phase 3)Study completedNCT02502773
What this trial is testing

Fluid Loading in Abdominal Surgery: Saline Versus Hydroxyethyl Starch (FLASH Study)

Who this might be right for
Postoperative MorbidityPostoperative Mortality
University Hospital, Clermont-Ferrand 826
Not applicableStudy completedNCT02936089
What this trial is testing

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

Who this might be right for
Acute Myeloid LeukemiaRisk Stratification
Nanfang Hospital, Southern Medical University 207
Not applicableWithdrawnNCT03213574
What this trial is testing

Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Who this might be right for
Vascular HypotensionHypovolemiaHypervolemia
Loma Linda University
Testing effectiveness (Phase 2)Looking for participantsNCT06702033
What this trial is testing

The Minimalist Trial-2

Who this might be right for
HPV-Related Oropharynx Squamous Cell Carcinoma
Washington University School of Medicine 142
Next Page